Protirelin
Other Research Peptidesaka TRH · thyrotropin-releasing hormone · synthetic TRH
Overview
Protirelin is synthetic thyrotropin-releasing hormone (TRH). Historically used as a diagnostic pituitary-thyroid challenge agent. Current U.S. public labeling on DailyMed reflects a compounded product, and PubChem notes protirelin is not currently available in an FDA-approved product.
Mechanism
TRH increases release of TSH from the anterior pituitary and also increases prolactin release. After intravenous administration, plasma half-life is about 5 minutes. Diagnostic value is in assessing thyroid function as an adjunct to other tests and in distinguishing pituitary from hypothalamic dysfunction when interpreted alongside the rest of the endocrine workup.